EP2855448
5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.5.2013EP published:
8.2.2017EP application number:
13723910.9
EPO information:
European Patent Register
Max expiry date:
13.5.2033
Title:
5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF
Timeline
Today
14.5.2013EP application
8.2.2017EP Publication
Owner
Name:
Cancer Research Technology LtdAddress:
Angel Building, 407 St John Street, London, Greater London EC1V 4AD, GB
Inventor
Name:
COLLINS, IanAddress:
SuttonSurrey SM2 5NG, GB
Name:
MATTHEWS, Thomas PeterAddress:
SuttonSurrey SM2 5NG, GB
Name:
FARIA DA FONSECA MCHARDY, TatianaAddress:
SuttonSurrey SM2 5NG, GB
Name:
OSBORNE, JamesAddress:
Saffron WaldenEssex CB10 1XL, GB
Name:
LAINCHBURY, MichaelAddress:
HarlowEssex CM19 5TR, GB
Name:
WALTON, Michael IanAddress:
SuttonSurrey SM2 5NG, GB
Name:
GARRETT, Michelle DawnAddress:
CanterburyKent CT5 3EU, GB
Priority
Number:
201261647200 PDate:
15.5.2012Country:
US
Classification
Categories:
C07D 401/12, A61K 31/506, A61P 35/00